|
1
|
Plucinski MM, Dimbu PR, Macaia AP,
Ferreira CM, Samutondo C, Quivinja J, Afonso M, Kiniffo R, Mbounga
E, Kelley JS, et al: Efficacy of artemether-lumefantrine,
artesunate-amodiaquine, and dihydroartemisinin-piperaquine for
treatment of uncomplicated Plasmodium falciparum malaria in Angola,
2015. Malar J. 16:622017. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Thanh NV, Thuy-Nhien N, Tuyen NT, Tong NT,
Nha-Ca NT, Dong LT, Quang HH, Farrar J, Thwaites G, White NJ, et
al: Rapid decline in the susceptibility of Plasmodium falciparum to
dihydroartemisinin-piperaquine in the south of Vietnam. Malar J.
16:272017. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Mao H, Gu H, Qu X, Sun J, Song B, Gao W,
Liu J and Shao Q: Involvement of the mitochondrial pathway and
Bim/Bcl-2 balance in dihydroartemisinin-induced apoptosis in human
breast cancer in vitro. Int J Mol Med. 31:213–218. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Singh NP, Lai HC, Park JS, Gerhardt TE,
Kim BJ, Wang S and Sasaki T: Effects of artemisinin dimers on rat
breast cancer cells in vitro and in vivo. Anticancer Res.
31:4111–4114. 2011.PubMed/NCBI
|
|
5
|
Lai H, Nakase I, Lacoste E, Singh NP and
Sasaki T: Artemisinin-transferrin conjugate retards growth of
breast tumors in the rat. Anticancer Res. 29:3807–3810.
2009.PubMed/NCBI
|
|
6
|
Noori S and Hassan ZM: Dihydroartemisinin
shift the immune response towards Th1, inhibit the tumor growth in
vitro and in vivo. Cell Immunol. 271:67–72. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Chen T, Li M, Zhang R and Wang H:
Dihydroartemisinin induces apoptosis and sensitizes human ovarian
cancer cells to carboplatin therapy. J Cell Mol Med. 13:1358–1370.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Handrick R, Ontikatze T, Bauer KD, Freier
F, Rübel A, Dürig J, Belka C and Jendrossek V: Dihydroartemisinin
induces apoptosis by a Bak-dependent intrinsic pathway. Mol Cancer
Ther. 9:2497–2510. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Hu W, Chen SS, Zhang JL, Lou XE and Zhou
HJ: Dihydroartemisinin induces autophagy by suppressing NF-κB
activation. Cancer Lett. 343:239–248. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Jia G, Kong R, Ma ZB, Han B, Wang YW, Pan
SH, Li YH and Sun B: The activation of c-Jun
NH2-terminal kinase is required for
dihydroartemisinin-induced autophagy in pancreatic cancer cells. J
Exp Clin Cancer Res. 33:82014. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Kumar D, Shankar S and Srivastava RK:
Rottlerin-induced autophagy leads to the apoptosis in breast cancer
stem cells: Molecular mechanisms. Mol Cancer. 12:1712013.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Desai S, Liu Z, Yao J, Patel N, Chen J, Wu
Y, Ahn EE, Fodstad O and Tan M: Heat shock factor 1 (HSF1) controls
chemoresistance and autophagy through transcriptional regulation of
autophagy-related protein 7 (ATG7). J Biol Chem 29,. 288:9165–9176.
2013. View Article : Google Scholar
|
|
13
|
Wilson EN, Bristol ML, Di X, Maltese WA,
Koterba K, Beckman MJ and Gewirtz DA: A switch between
cytoprotective and cytotoxic autophagy in the radiosensitization of
breast tumor cells by chloroquine and vitamin D. Horm Cancer.
2:272–285. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Levine B and Yuan J: Autophagy in cell
death: An innocent convict? J Clin Invest. 115:2679–2688. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Qu X, Yu J, Bhagat G, Furuya N, Hibshoosh
H, Troxel A, Rosen J, Eskelinen EL, Mizushima N, Ohsumi Y, et al:
Promotion of tumorigenesis by heterozygous disruption of the beclin
1 autophagy gene. J Clin Invest. 112:1809–1820. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Yue Z, Jin S, Yang C, Levine AJ and Heintz
N: Beclin 1, an autophagy gene essential for early embryonic
development, is a haploinsufficient tumor suppressor. Proc Natl
Acad Sci USA. 100:pp. 15077–15082. 2003; View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Nemoto T, Tanida I, Tanida-Miyake E,
Minematsu-Ikeguchi N, Yokota M, Ohsumi M, Ueno T and Kominami E:
The mouse APG10 homologue, anE2-like enzyme for Apg12p conjugation,
facilitates MAP-LC3 modification. J Biol Chem. 278:39517–39526.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Mizushima N, Yamamoto A, Hatano M,
Kobayashi Y, Kabeya Y, Suzuki K, Tokuhisa T, Ohsumi Y and Yoshimori
T: Dissection of autophagosome formation using Apg5-deficient mouse
embryonic stem cells. J Cell Biol. 152:657–667. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Gonzalez Y, Aryal B, Chehab L and Rao VA:
Atg7- and Keap1-dependent autophagy protects breast cancer cell
lines against mitoquinone-induced oxidative stress. Oncotarget.
5:1526–1537. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Caramés B, Hasegawa A, Taniguchi N, Miyaki
S, Blanco FJ and Lotz M: Autophagy activation by rapamycin reduces
severity of experimental osteoarthritis. Ann Rheum Dis. 71:575–581.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Pan T, Rawal P, Wu Y, Xie W, Jankovic J
and Le W: Rapamycin protects against rotenone-induced apoptosis
through autophagy induction. Neuroscience. 164:541–551. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Montoro E, Lemus D, Echemendia M, Martin
A, Portaels F and Palomino JC: Comparative evaluation of the
nitrate reduction assay, the MTT test, and theresazurin microtitre
assay for drug susceptibility testing of clinical isolatesof
Mycobacterium tuberculosis. J Antimicrob Chemother. 55:500–505.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Harrison B, Kraus M, Burch L, Stevens C,
Craig A, Gordon-Weeks P and Hupp TR: DAPK-1 binding to a linear
peptide motif in MAP1B stimulates autophagy and membrane blebbing.
J Biol Chem. 283:9999–10014. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Inbal B, Bialik S, Sabanay I, Shani G and
Kimchi A: DAP kinase and DRP-1 mediate membrane blebbing and the
formation of autophagic vesicles during programmed cell death. J
Cell Biol. 157:455–468. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Liu Q, Shi X, Zhou X, Wang D, Wang L and
Li C: Effect of autophagy inhibition on cell viability and cell
cycle progression in MDA-MB-231 human breast cancer cells. Mol Med
Rep. 10:625–630. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Overbergh L, Valckx D, Waer M and Mathieu
C: Quantification of murine cytokine mRNAs using real time
quantitative reverse transcriptase PCR. Cytokine. 11:305–312. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Kyoto Encyclopedia of Genes and Genomes
(KEGG): hsa05200: Pathways in cancer. KEGG source record: clv04140:
Regulation of autophagy. http://www.kegg.jp/kegg-bin/highlight_pathway?scale=1.0&map=map04140&keyword=autophagyJanuary
17–2018
|
|
28
|
Du XX, Li YJ, Wu CL, Zhou JH, Han Y, Sui
H, Wei XL, Liu L, Huang P, Yuan HH, et al: Initiation of apoptosis,
cell cycle arrest and autophagy of esophageal cancer cells by
dihydroartemisinin. Biomed Pharmacother. 67:417–424. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Wu GS, Lu JJ, Guo JJ, Huang MQ, Gan L,
Chen XP and Wang YT: Synergistic anti-cancer activity of the
combination of dihydroartemisinin and doxorubicin in breast cancer
cells. Pharmacol Rep. 65:453–459. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Zhang F, Ma Q, Xu Z, Liang H, Li H, Ye Y,
Xiang S, Zhang Y, Jiang L, Hu Y, et al: Dihydroartemisinin inhibits
TCTP-dependent metastasis in gallbladder cancer. J Exp Clin Cancer
Res. 36:682017. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Lemke D, Pledl HW, Zorn M, Jugold M, Green
E, Blaes J, Löw S, Hertenstein A, Ott M, Sahm F, et al: Slowing
down glioblastoma progression in mice by running or the
anti-malarial drug dihydroartemisinin? Induction of oxidative
stress in murine glioblastomatherapy. Oncotarget. 7:56713–56725.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Zhao J, Pan Y, Li X, Zhang X, Xue Y, Wang
T, Zhao S and Hou Y: Dihydroartemisinin and curcumin
synergistically induce apoptosis in SKOV3 cells via upregulation of
MiR-124 targeting midkine. Cell Physiol Biochem. 43:589–601. 2017.
View Article : Google Scholar : PubMed/NCBI
|
